Effective on July 15, 2019, the Board of Directors of Heron Therapeutics, Inc. appointed John Poyhonen as Executive Vice President, Chief Commercial Officer for the Company. In connection with his appointment to this position, Mr. Poyhonen tendered his resignation as a member of the Audit Committee of the Board and the Compensation Committee of the Board. Mr. Poyhonen will remain as a member of the Board.